Cellular Biochemistry and Biophysics Program, Memorial Sloan-Kettering Cancer Center, New York 10021
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The regulation of cadherin-mediated adhesion at the cell surface underlies several morphogenetic processes. To investigate the role of cadherin regulation in morphogenesis and to begin to analyze the molecular mechanisms of cadherin regulation, we have screened for monoclonal antibodies (mAbs) that allow us to manipulate the adhesive state of the cadherin molecule.
Xenopus C-cadherin is regulated during convergent extension movements of gastrulation. Treatment of animal pole tissue explants (animal caps) with the mesoderm-inducing factor activin induces tissue elongation and decreases the strength of C-cadherin-mediated adhesion between blastomeres (Brieher, W.M., and B.M. Gumbiner. 1994. J. Cell Biol. 126:519-527). We have generated a mAb to C-cadherin, AA5, that restores strong adhesion to activin-treated blastomeres. This C-cadherin activating antibody strongly inhibits the elongation of animal caps in response to activin without affecting mesodermal gene expression. Thus, the activin-induced decrease in C-cadherin adhesive activity appears to be required for animal cap elongation.
Regulation of C-cadherin and its activation by mAb AA5 involve changes in the state of C-cadherin that encompass more than changes in its homophilic binding site. Although mAb AA5 elicited a small enhancement in the functional activity of the soluble C-cadherin ectodomain (CEC1-5), it was not able to restore cell adhesion activity to mutant C-cadherin lacking its cytoplasmic tail. Furthermore, activin treatment regulates the adhesion of Xenopus blastomeres to surfaces coated with two other anti-C-cadherin mAbs, even though these antibodies probably do not mediate adhesion through a normal homophilic binding mechanism. Moreover, mAb AA5 restores strong adhesion to these antibodies. mAb AA5 only activates adhesion of blastomeres to immobilized CEC1-5 when it binds to C-cadherin on the cell surface. It does not work when added to CEC1-5 on the substrate. Together these findings suggest that the regulation of C-cadherin by activin and its activation by mAb AA5 involve changes in its cellular organization or interactions with other cell components that are not intrinsic to the isolated protein.
Key words: adhesion; activin; C-cadherin; morphogenesis; Xenopus ![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
THE regulation of cadherin-mediated adhesion is important for many morphogenetic processes (Gumbiner, 1992, 1996
). Most apparent is the loss or gain
of cadherin expression, which is thought to control the extreme states of cell association in tissues (Takeichi, 1995
;
Gumbiner, 1996
). However, there is also evidence that
acute regulation of cadherin function at the cell surface is
important for tissue morphogenesis. Examples include E-cadherin regulation during mouse embryo compaction (Fleming and Johnson, 1988
), C-cadherin regulation during
Xenopus gastrulation (Brieher and Gumbiner, 1994
; Lee
and Gumbiner, 1995
), and N-cadherin regulation during neurite outgrowth (Bixby and Zhang, 1990
). Nevertheless,
the role of cadherin functional regulation in various morphogenetic processes is still not well known, nor are the
mechanisms underlying cadherin regulation well understood.
We have been studying the role of a Xenopus cadherin,
called C-cadherin, in the convergence and extension movements that drive morphogenesis during amphibian gastrulation (Brieher and Gumbiner, 1994). C-cadherin is the
major cadherin expressed in the blastula and early gastrula
and is largely responsible for holding the cells of the early
embryo together (Heasman et al., 1994
; Lee and Gumbiner, 1995
). Both the expression of dominant negative forms of C-cadherin and the overexpression of wild-type
C-cadherin perturb gastrulation movements, suggesting
that appropriate levels of cell adhesion are required for
normal morphogenesis (Lee and Gumbiner, 1995
).
The adhesive activity of C-cadherin at the cell surface is
decreased when animal cap tissue explants are induced by
the growth factor activin to undergo tissue elongation
(Brieher and Gumbiner, 1994) which results from convergence extension movements (Symes and Smith, 1987
). We
hypothesized that this regulation of C-cadherin activity is
important for the rearrangement of cells that underlies elongation of the tissue. Although perturbation by the
dominant negative cadherins is consistent with this hypothesis, a direct test requires that we manipulate the regulation of C-cadherin.
Little is known about the mechanisms underlying cadherin regulation. There is some evidence that phosphorylation cascades by the v-src and receptor tyrosine kinases
modulate cadherin-mediated adhesion (Behrens et al.,
1993). Tyrosine phosphorylation of
-catenin has been observed (Matsuyoshi et al., 1992
; Hamaguchi et al., 1993
),
but its physiological significance is uncertain (Takeda et al.,
1995
). Small rho-family GTPases may also affect cadherin-mediated adhesion (Hordijk et al., 1997
; Takaishi et al.,
1997
; Tokman et al., 1997
). A recent study suggests that
IQGAP may alter cadherin-catenin interaction (Kuroda
et al., 1998
), but alteration of the complex is not observed
in all cases of cadherin regulation (Behrens et al., 1993
;
Brieher and Gumbiner, 1994
). Even accepting that such intracellular signal transduction events are causally linked
to regulation of cadherin-mediated adhesion, there is still
a need to understand how structural modifications or rearrangements of cadherins at the cell surface regulate the
state of cell-cell adhesion. By comparison, integrins are
thought to be regulated either by affinity modulation or by
changes in lateral clustering (Schwartz et al., 1995
; Stuiver
and O'Toole, 1995
; Humphries, 1996
).
One successful approach to the analysis of integrin regulation has been the use of specific mAbs that either activate the high adhesive state or bind selectively to activated
integrins (Schwartz et al., 1995; Stuiver and O'Toole, 1995
;
Humphries, 1996
). Therefore, we decided to search for
C-cadherin activating antibodies and to use these antibodies
to investigate the mechanism of cadherin regulation and to
evaluate the role of C-cadherin regulation in the convergence extension-like elongation of the Xenopus animal cap.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Protein Purification and Production of mAbs
CEC1-5 protein was purified from conditioned media as reported previously (Brieher et al., 1996). Production of monoclonal antibodies was
based on methods previously described (Campbell, 1984
). Briefly, BALB/c
mice were immunized five times subcutaneously with 50 µg of purified
CEC1-5 protein in the presence of adjuvant. 3 d before time of killing,
mice were injected intraperitoneally with 100 µg of CEC1-5 protein in the
absence of adjuvant. Spleens were removed and spleen cells were fused
with Sp2 myeloma cells, and the resultant hybrid cells were transferred to
96-well plates. The supernatants were first screened by ELISA or immunoblots for reactivity against CEC1-5 protein. Positive anti-C-cadherin
producers were then screened for functional activity as described below.
Functional Screening Assay
To assay for C-cadherin binding activity on the blastomere surface, FluoSpheres beads (Molecular Probes, Inc.) were coated with purified soluble
C-cadherin ectodomain, CEC1-5 (Brieher et al., 1996). FluoSpheres beads
were coated with CEC1-5 protein according to the manufacturer's instructions. Briefly, FluoSpheres were coupled with CEC1-5 at a ratio of 1 µg of
protein per 1 µl of beads in 20 mM Hepes, 100 mM NaCl, 1 mM CaCl2, pH
7.2, for 1 h, and then BSA and Tris were added to the medium at a final concentration of 2 mg/ml and 20 mM (pH 7.2), respectively. After incubation for 1 h, the coated FluoSpheres were pelleted at 10,000 g for 10 min
and then resuspended at 10 times their original volume in 20 mM Hepes,
100 mM NaCl, pH 7.2. The suspension was briefly sonicated to obtain single particles as determined by fluorescence microscopy before the addition of 1 mM CaCl2.
Xenopus animal caps were excised from stage 8 embryos and dissociated to a single cell suspension by incubation in calcium- and magnesium-free medium (CMFM) (Brieher and Gumbiner, 1994) for 2 h in a 35 mm
dish coated with 1% agarose in the same buffer.
The screening assay was performed at room temperature. The dissociated blastomeres were incubated with 5 ng/ml activin for 1 h and then incubated with either the anti-CEC1-5 monoclonal hybridoma supernatant or RPMI medium (with 10% FCS) for 1 h. Calcium (final concentration = 2 mM) and CEC1-5-coated FluoSpheres (20 µl for each experiment) were added, and the mixture of blastomeres and FluoSpheres was agitated horizontally for 30 min. Specimens were examined with a Axioskop equipped with plan-APOCHROMATx40 objective. Hybridoma supernatants were screened for the ability to stimulate the binding of CEC1-5 protein-coated FluoSpheres to activin-induced blastomeres (Fig. 1).
|
Cell Lines, mAbs, and Fab Fragments
CHO K1 cells, CEC1-5 expressing CHO cells, full-length C-cadherin expression CHO cells (C-CHO), and tailless truncated C-cadherin expression CHO cells (CT-CHO) were described previously (Brieher et al.,
1996; Yap et al., 1998
).
To map the mAb AA5 binding epitope, cDNA encoding CEC1-5 and
CEC1-4, which lacks the fifth repeat, were transfected transiently in CHO
cells by lipofection as described previously (Brieher et al., 1996; Yap et al.,
1997b
).
Anti-C-cadherin mAbs (6B6 and 5G5) were described previously
(Brieher and Gumbiner, 1994). Large amounts of mAb AA5 were produced with a bioreactor by the mAb facility of Memorial Sloan-Kettering Cancer Center. AA5, 6B6, and nonimmune mouse IgG were purified from the supernatants using affinity chromatography on protein G-Sepharose column. Fab fragments of AA5, 6B6, and nonimmune mouse IgG
were prepared using papain digestion and purification by protein A-Sepharose as described previously (Campbell, 1984
).
SDS-PAGE and Western Blots
Cells or blastomeres were extracted in 1% NP-40 extraction buffer (1%
NP-40, 10 mM Hepes, 150 mM NaCl, 1.5 mM EDTA, pH 7.4), supplemented with protease inhibitors as described previously (Choi and Gumbiner, 1989). Volumes were adjusted to make all samples equal in protein
concentration by addition of SDS sample buffer, and proteins were separated by SDS-PAGE. Proteins were transferred to nitrocellulose membrane and probed with the mAbs AA5, 6B6, or nonimmune mouse IgG.
Immunolabeling was detected by the ECL detection system according to
the manufacturer's instructions ().
Embryos and Explants
Xenopus eggs and embryos were obtained by standard techniques (Kay
and Peng, 1991). All manipulations were at room temperature. Eggs were
squeezed into 1× MMR (100 mM NaCl, 2 mM KCl, 2 mM CaCl2, 1 mM
MgCl2, and 5 mM Hepes, pH 7.4), and embryos were reared in 0.1×
MMR. Embryos were dejellied in 2% cysteine HCl (pH 7.8-8.0). Staging
of embryos was according to Nieuwkoop and Faber (1967).
To analyze antibody effects on the elongation of activin-induced animal caps, Xenopus animal caps were isolated from stage 8 embryos and incubated in 1× MMR with or without activin (5 ng/ml) and either mAb AA5 Fab (1 µg/ml) or mouse IgG Fab (1 µg/ml) overnight at 15°C. The animal caps were analyzed by photographing and scoring for presence or absence of elongation.
RNA Injection
To construct the IL-2 receptor-C-cadherin cytoplasmic tail fusion
cDNA, PCR was used to attach 5' HindIII and 3' XbaI sites on the cytoplasmic tail of C-cadherin. The PCR product was fused in frame to the
IL-2
receptor using the HindIII and XbaI sites. The resulting fusion construct was subcloned into pCS2 and transcribed in vitro with SP6 as described (Funayama et al., 1995
; Fagotto et al., 1997
). 5 ng of mRNA was
injected into fertilized eggs at the one cell stage.
Analysis of RNA Expression by RT-PCR
For RT-PCR experiments, animal caps were removed from stage 8 embryos and incubated in activin (5 ng/ml) with or without AA5 Fab (5 µg/ml)
overnight at 15°C. 15 caps were used for each experiment. Total RNA was
extracted using the Ultraspec RNA isolation system (Biotecx Laboratories, Inc.). Various specific RNAs were detected by RT-PCR as described
previously (Fagotto et al., 1997). Primers were: for Goosecoid, 5': ACA
ACT GGA AGC ACT GGA and 3': TCA TAT TCC AGA GGA ACC;
for Brachyury, 5': GGA TCG TTA TCA CCT CTG and 3': GTG TAG
TCT GTA GCA GCA; for EF-1, 5': CAG ATT GGT GCT FFA TAT
GC and 3': AC TGC CTT GAT GAC TCC TAG.
Blastomere Adhesion Assays
For both aggregation assays and blastomere attachment assays, animal
caps of Xenopus were excised from stage 8 embryos and dissociated to single cell suspensions in CMFM. Five animal caps were used for each experiment. Dissociated blastomeres were incubated with 5 ng/ml activin for 60 min in agarose-coated dishes. Activin-induced blastomeres were transferred into 2% albumin-coated 1.5-ml centrifuge tube and incubated with
either AA5 Fab or nonimmune mouse IgG Fab for 30 min. For aggregation assays, treated blastomeres were moved back to the agarose-coated
dish, and subsequently aggregated at room temperature. Aggregation proceeded during a horizontal rocking in CMFM with 2 mM CaCl2 for 15 min. Cell aggregation was analyzed by photographing random fields from
each sample. For the attachment assays, substrates were prepared by spotting 10 µl of either 1 µg/ml CEC1-5, 1 µg/ml fibronectin, or of 10 µg of relevant mAb at a distance of 1 cm from the edge of 10-cm petri dishes.
Anti-C-cadherin mAbs 6B6 and 5G5 have been described previously (Brieher and Gumbiner, 1994). mAb BB 10 was used for the experiments using the IL-2
receptor. The entire dish was then blocked for 2 h with 10 mg/ml BSA in 1× MMR. 25 µl of a suspension of dissociated blastomeres
(5 animal cap equivalents per ml) was spotted on the region of the dish
coated with the substrate. The blastomeres were allowed to attach for 30 min after which the dish was swirled and the number of blastomeres remaining was counted.
Laminar-Flow Adhesion Assay for CHO Cells
The modified laminar-flow assay was performed as described previously
(Brieher et al., 1996; Yap et al., 1997b
, 1998
). 1-mm internal diameter glass
capillary tubes were coated with 5 µg/ml CEC1-5 in the presence of calcium for 8 h at 4°C. The capillary was subsequently blocked with 10 mg/ml
BSA for 2 h at room temperature. The coated capillary was connected to a
60-cm3 syringe attached to a syringe pump and mounted on an inverted microscope.
Full-length C-cadherin expression CHO cells (C-CHO) or tailless truncated C-cadherin expression CHO cells (CT-CHO) were harvested using
a procedure that leaves cadherins intact as described previously (Brieher
et al., 1996; Yap et al., 1998
). The laminar-flow assay was performed at
room temperature. The concentration of cells was adjusted to 2 × 105
cells/ml and either AA5 Fab, 6B6 Fab, or nonimmune mouse IgG Fab (final concentration at 1 µg/ml) was added to various cell suspensions. Cells
were drawn into the coated capillary from a reservoir using the pump. After 1 min, the flow was stopped and the cells were allowed to bind to the
surface under static conditions for 10 or 30 min. Capillaries were observed
with a phase microscope and the number of cells in a ×20 field was then
counted. Flow was initiated and the number of cells remaining in the field
was counted after 30 s. Subsequently, the flow was doubled every 30 s, and
the number of cells remaining in the field was counted at the end of each
time point.
Bead Aggregation Assay
To perform the bead aggregation assay, FluoSpheres were coated with CEC1-5 as described above. The coated FluoSpheres were sonicated to obtain single particles as determined by fluorescence microscopy. The aggregation assay was performed at room temperature. 20 µl of a suspension of coated FluoSpheres was used for each experiment. The coated FluoSpheres were transferred to an albumin-coated centrifuge tube and incubated with 2 mM CaCl2, 20 mM NaCl, and AA5 Fab or nonimmune mouse IgG Fab (final concentration at 1 µg/ml) for various time periods. As a control, the CEC1-5 protein-coated FluoSpheres were also incubated with 2 mM EDTA instead of calcium for various time periods. Samples of FluoSpheres aggregates were aliquoted and suprathreshold sized particle aggregates were counted using a Coulter counter.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Identification of a C-cadherin Activating Antibody
The adhesive activity of C-cadherin on the surface of Xenopus embryonic blastomeres is decreased in response
to activin treatment (Brieher and Gumbiner, 1994). We
therefore sought anti-C-cadherin mAbs that would restore the state of C-cadherin-mediated adhesion of activin-treated blastomeres to the same level as untreated blastomeres. To do so we modified an assay previously
used to measure C-cadherin regulation, which entailed the
binding of fluorescently labeled C-cadherin expressing
fibroblasts to the blastomeres (Brieher and Gumbiner,
1994
). In the modified assay, we used fluorescent beads
coated with purified C-cadherin ectodomain (CEC1-5) as
the binding probe in place of the fibroblasts (Fig. 1 A).
Numerous CEC1-5-coated beads bound to the surface of
untreated blastomeres (left), and treatment of blastomeres
with activin greatly reduced the number of beads bound (center).
mAbs were raised to CEC1-5 and screened first for reactivity to CEC1-5 by ELISA or Western blotting. The positive hybridoma supernatants were then screened in the functional assay described above for C-cadherin activating activity. Greater than 600 supernatants from 6 fusions were positive for reactivity with C-cadherin in ELISA. Of these, only one exhibited clear reproducible activating activity. This mAb, designated AA5, stimulated the binding of CEC1-5-coated beads to activin-treated blastomeres (Fig. 1 A, right). mAb AA5 was therefore subcloned and characterized further.
mAb AA5 binds to purified CEC1-5 in Western blots (Fig. 1 B) and specifically recognizes C-cadherin expressed in CHO cells (Fig. 1 C). We were also able to map the AA5 binding epitope to the fifth extracellular cadherin repeat that is predicted to lie nearest to the membrane (Fig. 1 D). CEC1-5 and CEC1-4, which lacks the fifth repeat, were expressed transiently in CHO cells and immunoblotted with either mAb AA5 or another anti-C-cadherin mAb (6B6) described previously. Although mAb 6B6 recognizes both CEC1-5 and CEC1-4, mAb AA5 recognizes only the full-length ectodomain.
Although mAb AA5 stimulates CEC1-5-coated bead
binding to blastomeres, we wished to determine whether it
stimulated blastomere adhesion using more standard types
of adhesion assays. Furthermore, to rule out artifactual adhesion due to crosslinking by the bivalent antibody, we
also tested monovalent Fab fragments of mAb AA5. Fab
fragments of mAb AA5 also stimulated CEC1-5-coated
beads binding to blastomeres (data not shown). In all further experiments described, purified Fab fragments of
mAb AA5 were used (although still referred to as mAb
AA5). Activin treatment reduces the rate of Ca2+-dependent aggregation of animal cap blastomeres that had been dissociated by Ca2+ removal (Brieher and Gumbiner,
1994) (Fig. 2 A, left and center). Inclusion of mAb AA5
in the aggregation assay stimulated the rate of blastomere aggregation of activin-treated blastomeres, producing larger aggregates after the same time interval (Fig. 2
A, right). We also examined the activity of mAb AA5 in a
cell attachment assay (Fig. 2 B). Attachment of dissociated
blastomeres to surfaces coated with CEC1-5 was assayed.
No attachment to BSA-coated surfaces was observed (data
not shown). Activin treatment reduced the number of
blastomeres that adhered to CEC1-5 under gentle shaking
conditions, and mAb AA5 significantly increased the number of activin-treated blastomeres that adhered to CEC1-5.
Thus, monovalent Fab fragments of mAb AA5 stimulated
C-cadherin-mediated adhesion of activin-treated blastomeres to near the level of adhesion of untreated blastomeres.
|
Inhibition of Activin-induced Morphogenetic Movements by mAb AA5
Activin induces Xenopus animal cap explants to elongate
as a result of convergent extension movements (Symes
and Smith, 1987; Brieher and Gumbiner, 1994
) (Fig. 3).
We proposed that the activin-induced decrease in C-cadherin-mediated adhesion is necessary for tissue elongation
(Brieher and Gumbiner, 1994
). To test this hypothesis, we
asked whether mAb AA5, which maintains high levels of
C-cadherin-mediated adhesion even after activin treatment, would affect animal cap elongation (Fig. 3, A and
B). As described previously, activin induced ~95% of the
animal caps to elongate significantly, forming asymmetric
structures. In the absence of activin, all of the animal caps
form nearly spherical structures. mAb AA5 strongly inhibited animal cap elongation in response to activin (Fig. 3 A,
far right). Only ~30% of the animal caps formed asymmetric structures that could be scored as elongated (Fig. 3
B), and even these were relatively stunted compared to
the nonimmune IgG control. Although the majority of the
mAb AA5-treated caps did not elongate significantly, they appeared "lumpier" than the smooth spherical structures
formed in the absence of activin, suggesting that mAb
AA5 did not completely block all morphogenetic movement. A different mAb that inhibits C-cadherin-mediated
adhesion, 6B6, did not block elongation to the same extent
as mAb AA5, even though it did affect the morphology of
the elongated caps. Thus, preventing the activin-induced
decrease in C-cadherin-mediated adhesion significantly
inhibited the morphogenetic elongation of the tissue, indicating that the change in C-cadherin-mediated adhesion is
required for the process.
|
mAb AA5 could affect morphogenesis of the animal
caps in two ways; either directly by affecting the physical
adhesion between blastomeres in the tissue, or indirectly
by somehow inhibiting the whole process of mesoderm induction by activin. The latter possibility was tested by determining whether mAb AA5 inhibited the induction of
mesoderm specific genes using RT-PCR analysis (Fig. 3
C). Two mesodermal specific markers were analyzed.
Goosecoid is a marker for dorsal mesoderm, and its expression is associated with convergent extension morphogenesis (Smith et al., 1991). Brachyury is a marker for ventral-lateral mesoderm, and while its expression can be
induced by activin, it is often expressed in untreated animal caps when they are large and/or taken from later stage
blastulae (Cho et al., 1991
). Similar to previous publications (Smith et al., 1991
), we find that activin induces goosecoid expression in animal caps, yet mAb AA5 did
not inhibit goosecoid induction. Also, mAb AA5 did not
inhibit the expression of brachyury, which, in this experiment, was expressed even without activin treatment. Thus,
mAb AA5 does not inhibit general mesodermal gene expression in response to activin. Its effects on morphogenesis are more likely due to its direct effects on C-cadherin-
mediated adhesion.
Analysis of Mode of Action of mAb AA5
Experiments were undertaken to determine how mAb
AA5 activates C-cadherin. For integrins, there are two
general classes of activating mAbs. One class, exemplified
by anti-3 mAbs including P41 (O'Toole et al., 1990
), Ab
62 (O'Toole et al., 1990
), and D3GP3 (Kouns et al., 1990
),
binds to and stabilizes a high-affinity conformation of the
isolated integrin protein. The second class is more complex and requires cellular processes to activate the integrin
(Shattil et al., 1985
; Dransfield and Hogg, 1990
). To determine whether mAb AA5 influences the homophilic binding function of the purified CEC1-5 ectodomain, its effect
on the aggregation of CEC1-5-coated beads was assayed.
Previous experiments showed that bead aggregation depended on calcium and the dimerization of CEC1-5 and was
strongly inhibited by inhibitory anti-C-cadherin mAbs
6B6 and 5G5 (Brieher et al., 1996
). In contrast, mAb AA5 weakly, but reproducibly enhanced the rate of CEC1-5-coated bead aggregation (Fig. 4 C). This suggests that
mAb AA5 can affect to some extent the intrinsic homophilic binding function of the CEC1-5 ectodomain independent of cellular context.
|
To try to analyze the effect of mAb AA5 on C-cadherin
in a simple cellular context, its effect on the strength of
C-cadherin-mediated adhesion when expressed in CHO
cells was assayed (Fig. 4). The strength of adhesion to purified CEC1-5 was measured by a laminar flow detachment assay described previously (Brieher et al., 1996; Yap
et al., 1997a
, 1998
). mAb AA5 has no significant effect on the strength of attachment of CHO cells expressing wild-type C-cadherin (Fig. 4 A). This suggests that in the context of CHO cells C-cadherin either exists in a completely
activated state (like blastomeres before treatment with
activin) or is somehow refractory to activation by
mAb AA5.
A mutant form of C-cadherin lacking its cytoplasmic tail
exhibits low levels of adhesion when expressed in CHO
cells (CT-CHO), reflecting its basic homophilic binding
activity (Brieher et al., 1996; Yap et al., 1998
). We wished
to determine whether mAb AA5 could induce a change in
the C-cadherin ectodomain that is normally provided by
the cytoplasmic tail and associated cytoskeletal proteins. mAb AA5 only weakly enhances the attachment strength
of CT-CHO cells (Fig. 4 B). This is consistent with the
bead aggregation assay and suggests that the mAb AA5
can affect to some extent the homophilic binding activity
of the protein in the absence of cytoplasmic interactions.
Note, however, that mAb AA5 was not able to restore full
cell adhesion activity to the tailless mutant C-cadherin
compared to wild-type C-cadherin, demonstrating that the
changes elicited by the antibody cannot substitute for the normal cytoplasmic interactions of the cadherin.
Regulation of cell adhesion may involve complex changes
in the state of the adhesion molecule other than modulation of binding affinity. Therefore, we investigated
whether activin and mAb AA5 could regulate C-cadherin-mediated adhesion independent of its homophilic
binding site. To do so, we assayed blastomere attachment to two anti-C-cadherin mAbs raised against portions of
C-cadherin expressed in bacteria, 6B6, and 5G5 (Brieher
and Gumbiner, 1994), which are not expected to interact
with C-cadherin via its homophilic binding site (Fig. 5).
Xenopus blastomeres do attach to surfaces coated with
these mAbs, and like attachment to CEC1-5, activin decreases the number of blastomeres that attach to the antibodies (Fig. 5 A). This effect is specific to C-cadherin,
because activin did not decrease attachment to other substrates. Activin did not affect the attachment of blastomeres to mAbs raised against another cell surface protein,
the IL-2
receptor ectodomain fused to the C-cadherin cytoplasmic tail (Fig. 5 C). Moreover, as reported previously
(Smith et al., 1990
), activin stimulates, instead of decreasing, attachment of blastomeres to fibronectin (Fig. 5 B). Therefore, activin specifically regulates the adhesion of
blastomeres to two different anti-C-cadherin mAbs as
well as adhesion by the normal C-cadherin homophilic interaction. Blastomere adhesion to mAbs 6B6 and 5G5 is
also activated by mAb AA5 (Fig. 5 A). Addition of mAb
AA5 stimulated the adhesion of activin-induced blastomeres to the mAbs to the same extent as it stimulated
adhesion to CEC1-5, the homophilic binding substrate.
Since mAbs 6B6 and 5G5 are highly unlikely to interact
with C-cadherin through its homophilic binding site, these
findings provide evidence that regulation of C-cadherin- mediated adhesion by activin and its activation by mAb
AA5 occur by mechanisms other than modulation of homophilic binding affinity.
|
These findings raise an important question about the observations in Fig. 4, B and C. The intrinsic homophilic binding properties of the cadherin ectodomain, CEC1-5, are enhanced by mAb AA5. To what extent can the effects of mAb AA5 on the homophilic binding activity of CEC1-5 account for the reversal of activin-induced regulation of C-cadherin on the blastomere surface? To try to address this question, we asked whether the activation of blastomere adhesion by mAb AA5 occurs primarily through direct effects on the purified CEC1-5 ectodomain or through effects on the normal C-cadherin expressed on the cell surface (Fig. 6). Blastomere adhesion to CEC1-5 provides C-cadherin in both contexts, purified ectodomain on an inert surface and normal C-cadherin and its associated cytoplasmic proteins at the blastomere surface. mAb AA5 was added either to the surface-bound CEC1-5 or to the activin-treated blastomeres separately. mAb AA5 had little or no effect when added to the surface-bound CEC1-5, but exerted its full effect when added to the blastomeres. This finding suggests that the enhanced homophilic binding activity of the cadherin ectodomain does not account significantly for the activation of adhesion by mAb AA5. Activation by mAb AA5 probably occurs primarily by altering C-cadherin function in the context of the cell surface.
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Activating mAbs have provided powerful tools to analyze
the regulation of integrin-mediated adhesion (Schwartz et al.,
1995; Stuiver and O'Toole, 1995
; Humphries, 1996
). Until
now, this approach had not been used for other types of
adhesion molecules. Since cadherins are thought to be regulated at the cell surface like the integrins, it seemed likely
that they would be good targets for a similar approach. We
have been able to generate such a cadherin-activating antibody by taking advantage of our ability to detect two adhesive states of C-cadherin on the surface of Xenopus
blastomeres, a high adhesive state and a lower adhesive
state that is induced by treatment with the mesoderm-
inducing factor activin (Brieher and Gumbiner, 1994
). The
mAb AA5 activates C-cadherin from the low to the higher
adhesive state, effectively reversing the response of C-cadherin to activin treatment.
mAb AA5 provided a tool to test the requirement for
C-cadherin regulation in the elongation of the Xenopus
animal cap. Previously our laboratory had established a
correlation between C-cadherin regulation and elongation
(Brieher and Gumbiner, 1994). It has been shown that interference with normal C-cadherin function by overexpression or by dominant negative mutations perturbs morphogenesis, but interpretation of these findings is limited
because of the requirement of C-cadherin in overall tissue
integrity (Heasman et al., 1994
; Lee and Gumbiner, 1995
).
What is needed instead is a selective inhibition of the activin-induced regulation of adhesion in Xenopus blastomeres. mAb AA5 achieves this selective inhibition,
since it blocks the response of C-cadherin to activin treatment, but has no effect on C-cadherin-mediated adhesion
in uninduced blastomeres, or in CHO cells expressing
wild-type C-cadherin. mAb AA5 strongly inhibits activin-induced elongation of Xenopus animal caps without affecting induction of mesoderm by activin. These findings
provide direct evidence that the downregulation in C-cadherin adhesive activity is required for the morphogenetic movements underlying tissue elongation.
Different roles for C-cadherin regulation in tissue elongation can be envisioned (Brieher and Gumbiner, 1994).
Elongation of tissues in the early Xenopus embryo is due
to convergence and extension, a morphogenetic process
that involves local cell rearrangements (Keller, 1987
;
Gumbiner, 1992
). To rearrange, cells must exchange neighbors despite being held together by C-cadherin.
Downregulation of C-cadherin activity might play a passive role in morphogenesis, by simply allowing cells to
move relative to each other, with motility driven by another mechanism. In this regard, it is interesting that the
activation state of integrin in the Xenopus embryo and animal caps is also regulated by activin (Ramos and DeSimone, 1996
). Alternatively, a more active role for C-cadherin in these movements is also possible, similar to the
roles of integrins in the locomotion of individual cells on a
substratum. Convergent extension requires cell movement
on the surface of another cell (Keller, 1987
; Gumbiner,
1992
), and C-cadherin could act as the adhesive molecule
with which a moving cell generates traction. Indeed, cadherin-based cell motility seems plausible, because neurite
outgrowth can occur on purified N-cadherin (Bixby and Zhang, 1990
). In an active role, the global downregulation
of C-cadherin activity detected in these experiments may
reflect a more complex spatial and temporal regulation
needed to produce net movement, as is thought to occur
with integrins in locomoting cells (Lauffenburger and Horwitz, 1996
).
We have begun to use mAb AA5 to try to elucidate the
molecular mechanisms underlying C-cadherin regulation.
Activating mAbs have been helpful in clarifying the mechanisms of integrin regulation, and provide valuable examples for comparison (Schwartz et al., 1995; Stuiver and
O'Toole, 1995
; Humphries, 1996
). There are two classes of
mAbs that activate the adhesive function of the platelet integrin, gpIIbIIIa (Stuiver and O'Toole, 1995
; Humphries,
1996
). One class acts by binding to and stabilizing the high-
affinity conformation of the isolated protein, directly enhancing its binding to its ligand, fibrinogen (Stuiver and
O'Toole, 1995
; Humphries, 1996
). Another class of mAbs
acts in a more complex and less understood manner by activating adhesion only in the context of the cell, suggesting
a role for other plasma membranes or cytoplasmic components (Stuiver and O'Toole, 1995
; Humphries, 1996
). For
C-cadherin and mAb AA5 it is more difficult to make the
distinction between these two modes of regulation, since
we do not have a method for measuring homophilic binding affinity. Nevertheless, knowledge about integrin-activating mAbs provides a conceptual framework for the
analysis of cadherin-activating mAbs.
C-cadherin downregulation by activin and activation by
mAb AA5 most likely occurs as a result of altering the
state of the protein in the cell membrane beyond simple
changes in the affinity of the homophilic binding site. Regulation of C-cadherin function by activin is apparent even
when blastomeres attach to two different anti-C-cadherin
mAbs. mAb AA5 activates attachment of activin-induced blastomeres to these antibodies, providing evidence that
this regulation occurs by a mechanism similar to the normal regulation of adhesion to C-cadherin. Because C-cadherin is unlikely to attach to these mAbs (6B6 and 5G5)
via its usual homophilic binding mechanism, another more
global property of C-cadherin is probably altered during
regulation. Examples of such a property include the state of oligomerization or clustering of the cadherin, its attachment to the actin cytoskeleton, or a global change in the
conformation of the protein (Gumbiner, 1996; Yap et al.,
1997a
,b).
mAb AA5 is able to enhance somewhat the rate of bead
aggregation mediated by the soluble C-cadherin ectodomain (CEC1-5), suggesting that mAb AA5 causes changes
intrinsic to the protein. However, the effect of mAb AA5
on the isolated ectodomain does not seem to contribute
quantitatively to activation of blastomere adhesion. Using
an adhesion assay involving both the immobilized ectodomain and cell-associated C-cadherin, we found that
mAb AA5 could not activate adhesion when added to the
immobilized CEC1-5, but it was able to fully activate adhesion when added to the cells alone. Therefore, mAb
AA5 is able to activate C-cadherin only when it is in a
cellular context and similar to the second class of integrin-activating mAb. Since mAb AA5 must initiate its effects
through binding to the extracellular region, it may be possible to reconcile an intrinsic change in CEC1-5 with a requirement for cellular context. For example, mAb AA5
could induce a conformational change in the extracellular region that would both exert a very small effect on its homophilic binding activity (detectable with sufficient sensitivity), and transduce a signal across the membrane to effect a change in cytoplasmic function or interactions.
There is evidence that the cadherin ectodomain can transmit a signal across the membrane that influences its organization. C-cadherin clustering is ligand-dependent, occurring only when cells specifically attach to C-cadherin (Yap
et al., 1997a). It is possible that mAb AA5 binding mimics
an initial homophilic binding event that leads to a change
in C-cadherin organization.
Determination of the molecular effect of mAb AA5 on
the C-cadherin adhesive complex would provide interesting insights into the mechanism of cadherin regulation.
mAb AA5 binds to the fifth extracellular cadherin repeat
(EC5), which is adjacent to the membrane. This domain
differs somewhat in sequence from the other four cadherin
repeats in the classical cadherins, but its specific function is
not yet known (Takeichi, 1995; Gumbiner, 1996
). Lateral dimerization seems to be required for cadherin adhesive
function (Brieher et al., 1996
), and it would be interesting
to know whether mAb AA5 binds preferentially to dimers
or induces dimerization. Despite several attempts, we
have been unable to detect any differences in binding to
monomeric or dimeric species of soluble CEC1-5, or any
changes in their relative distributions (our unpublished observations). Also, we have not yet observed any changes
in the amounts of
-catenin or
-catenin interacting with
C-cadherin in Xenopus in response to activin treatment
(Brieher and Gumbiner, 1994
). Changes in other protein
interactions, or more subtle or transient changes that we
have not yet been able to measure, may underlie regulation. Nonetheless, mAb AA5 provides us with an additional tool that we can use to help understand the molecular mechanisms underlying the regulation of C-cadherin-mediated adhesion by activin signaling.
![]() |
Footnotes |
---|
Received for publication 10 November 1998 and in revised form 8 December 1998.
Address correspondence to Dr. Barry M. Gumbiner, Cellular Biochemistry and Biophysics Program, Memorial Sloan-Kettering Cancer Center,
Box 564, 1275 York Avenue, New York, NY 10021. Tel.: (212) 639-6146. Fax: (212) 717-3047. E-mail: b-gumbiner{at}ski.mskcc.org
This research was funded by National Institutes of Health grant
GM52717 awarded to B.M. Gumbiner and the Cancer Center Support grant
NCI-P30-CA-08748 to the Memorial Sloan-Kettering Cancer Center.
We thank members of the Gumbiner laboratory for their support during this project and Cara Gottardi, Kathleen Guger, Richard Nelson, and Carien Niessen for critically reading the manuscript. We give special thanks to Ellen Wong for her help in mapping the C-cadherin binding region for mAb AA5.
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1. |
Behrens, J.,
L. Vakaet,
R. Friis,
E. Winterhager,
F.V. Roy,
M.M. Mareel, and
W. Birchmeier.
1993.
Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/![]() |
2. | Bixby, J.L., and R. Zhang. 1990. Purified N-Cadherin is a potent substrate for the rapid induction of neurite outgrowth. J. Cell Biol. 110: 1253-1260 [Abstract]. |
3. | Brieher, W.M., and B.M. Gumbiner. 1994. Regulation of cadherin function during activin induced morphogenesis of Xenopus animal caps. J. Cell Biol. 126: 519-527 [Abstract]. |
4. | Brieher, W.M., A.S. Yap, and B.M. Gumbiner. 1996. Lateral dimerization is required for the homophilic binding activity of C-Cadherin. J. Cell Biol. 135: 487-496 [Abstract]. |
5. | Campbell, A.M. 1984. Monoclonal antibody technology. In Laboratory Techniques in Biochemistry and Molecular Biology. R.H.a.v.K. Burdon, editor. Elsevier/North-Holland Biomedical Press, Amsterdam. 1-265. |
6. | Cho, K.W.Y., B. Blumberg, H. Steinbeisser, and E.M. De Robertis. 1991. Molecular nature of Spemann's organizer: the role of Xenopus homeobox gene goosecoid. Cell. 67: 1111-1120 |
7. | Choi, Y.S., and B. Gumbiner. 1989. Expression of cell adhesion molecule E-cadherin in Xenopus embryos begins at gastrulation and predominates in the ectoderm. J. Cell Biol. 108: 2449-2458 [Abstract]. |
8. | Dransfield, I., and N. Hogg. 1990. Regulated expression of Mg2+ binding epitope on leukocyte integrin alpha subunits. EMBO (Eur. Mol. Biol. Organ.) J. 8: 3759-3765 [Abstract]. |
9. |
Fagotto, F.,
K. Guger, and
B.M. Gumbiner.
1997.
Induction of the primary dorsalizing center in Xenopus by the wnt/GSK/![]() |
10. | Fleming, T.P., and M.H. Johnson. 1988. From egg to epithelium. Ann. Rev. Cell Biol. 4: 459-485 . |
11. |
Funayama, N.,
F. Fagotto,
P. McCrea, and
B.M. Gumbiner.
1995.
Embryonic
axis induction by the armadillo repeat domain of ![]() |
12. | Gumbiner, B.M.. 1992. Epithelial morphogenesis. Cell. 69: 385-387 |
13. | Gumbiner, B.M.. 1996. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell. 84: 345-357 |
14. | Hamaguchi, M., N. Matsuyoshi, Y. Ohnishi, B. Gotoh, M. Takeichi, and Y. Nagai. 1993. p60v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system. EMBO (Eur. Mol. Biol. Organ.) J. 12: 307-314 [Abstract]. |
15. |
Heasman, J.,
D. Ginsberg,
B. Geiger,
K. Goldstone,
T. Pratt,
C. Yoshida-Noro, and
C. Wylie.
1994.
A functional test for maternally inherited cadherin in
Xenopus shows its importance in cell adhesion at the blastula stage.
Development.
120:
49-57
|
16. |
Hordijk, P.L.,
J.P. ten Klooster,
R.A. van der Kammen,
F. Michiels,
L.C.J.M. Oomen, and
J.G. Collard.
1997.
Inhibition of invasion of epithelial cells by
Tiam1-Rac signaling.
Science.
278:
1464-1466
|
17. | Humphries, M.J.. 1996. Integrin activation: the link between ligand binding and signal transduction. Curr. Opin. Cell Biol. 8: 632-640 |
18. | Kay, B.K.. 1991. Xenopus laevis: practical uses in cell and molecular biology. Injections of oocytes and embryos. Methods Cell Biol. 36: 663-669 |
19. | Keller, R.. 1987. Cell rearrangement in morphogenesis. Zool. Sci. (Tokyo). 4: 763-779 . |
20. |
Kouns, W.C.,
C.D. Wall,
M.M. White,
C.F. Fox, and
L.K. Jennings.
1990.
A
conformation-dependent epitope of human platelet glycoprotein IIIa.
J.
Biol. Chem.
265:
20594-20601
|
21. | Kuroda, S., M. Fukata, M. Nakagawa, K. Fujii, T. Nakamura, T. Ookubo, I. Izawa, T. Nagase, N. Nomura, H. Tani, et al . 1998. Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin-mediated cell-cell adhesion. Science. 291: 832-835 . |
22. | Lauffenburger, D.A., and A.F. Horwitz. 1996. Cell migration: A physically integrated molecular process. Cell. 84: 359-369 |
23. | Lee, C.H., and B.M. Gumbiner. 1995. Disruption of gastrulation movements in Xenopus by a dominant negative mutant for C-cadherin. Dev. Biol. 171: 363-373 |
24. | Matsuyoshi, N., M. Hamaguchi, S. Taniguchi, A. Nagafuchi, S. Tsukita, and M. Takeichi. 1992. Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts. J. Cell Biol. 118: 703-714 [Abstract]. |
25. | Nieuwkoop, P.D., and J. Faber. 1967. Normal table of Xenopus laevis (Daudin). Elsevier/North-Holland Biomedical Press, Amsterdam. 252 pp. |
26. | O'Toole, T.E., J.C. Lofus, X.P. Du, A.A. Glass, Z.M. Ruggeri, S.J. Shattil, E.F. Plow, and M.H. Ginsberg. 1990. Affinity modulation of the alpha IIb beta 3 (platelet GPIIb-IIIa) is an intrinsic property of receptor. Cell Regul. 1: 883-893 |
27. | Ramos, J.W., and D.W. DeSimone. 1996. Xenopus embryonic cell adhesion to fibronectin: position-specific activation of RGD/synergy site-dependent migratory behavior at gastrulation. J. Cell Biol. 134: 227-240 [Abstract]. |
28. | Schwartz, M.A., M.D. Schaller, and M.H. Ginsberg. 1995. Integrins: emerging paradigms of signal transduction. Annu. Rev. Cell Dev. Biol. 11: 549-600 . |
29. |
Shattil, S.J.,
J.A. Hoxie,
M. Cunningham, and
L.F. Brass.
1985.
Changes in the
platelet membrane glycoprotein IIb-IIIa complex during platelet activation.
J. Biol. Chem.
260:
11107-11114
|
30. | Smith, J.C., K. Symes, R.O. Hynes, and D. DeSimone. 1990. Mesoderm induction and the control of gastrulation in Xenopus laevis: the roles of fibronectin and integrins. Development. 108: 229-238 [Abstract]. |
31. | Smith, J.C., B.M.J. Price, J.B.A. Green, D. Weigel, and B.G. Herrmann. 1991. Expression of a Xenopus homolog of Brachyury (T) in an immediate-early response to mesoderm induction. Cell. 67: 753-765 |
32. | Stuiver, I., and T.E. O'Toole. 1995. Regulation of integrin function and cellular adhesion. Stem Cells (Basel). 13: 250-262 [Abstract]. |
33. | Symes, K., and J.C. Smith. 1987. Gastrulation movements provide an early marker of mesoderm induction in Xenopus laevis. Development. 101: 339-349 [Abstract]. |
34. |
Takaishi, K.,
T. Sasaki,
H. Kotani,
H. Nishioka, and
Y. Takai.
1997.
Regulation
of cell-cell adhesion by Rac and Rho small G proteins in MDCK cells.
J.
Cell Biol.
139:
1047-1059
|
35. | Takeda, H., S. Nagafuchi, S. Yonemura, S. Tsukita, J. Behrens, W. Birchmeier, and S. Tsukita. 1995. V-src kinase shifts the cadherin-based cell adhesion from the strong to the weak state and catenin is not required for the shift. J. Cell Biol. 131: 1839-1847 [Abstract]. |
36. | Takeichi, M.. 1995. Morphogenetic roles of classic cadherins. Curr. Opin. Cell Biol. 7: 619-627 |
37. | Tokman, M.G., R.A. Porter, and C.L. Williams. 1997. Regulation of cadherin-mediated adhesion by the small GTP-binding protein Rho in small cell lung carcinoma cells. Cancer Res. 57: 1785-1793 [Abstract]. |
38. | Yap, A.S., W.M. Brieher, and B.M. Gumbiner. 1997a. Molecular and functional analysis of cadherin-based adherens junctions. Annu. Rev. Cell Dev. Biol. 13: 119-146 . |
39. | Yap, A.S., W.M. Brieher, M. Pruschy, and B.M. Gumbiner. 1997b. Lateral clustering of the adhesive ectodomain: a fundamental determinant of cadherin function. Curr. Biol. 7: 308-315 |
40. |
Yap, A.S.,
C.M. Niessen, and
B.M. Gumbiner.
1998.
The juxtamembrane region of the cadherin cytoplasmic tail supports lateral clustering, adhesive
strengthening, and interaction with p120ctn.
J. Cell Biol.
141:
779-789
|